The Daily AdvisorThe Daily Advisor Facebook ad: “Explore info about Retatrutide Clinical Trials for Obesity”
Ran for 21 days, from May 21 to June 11, 2026, the last day Crush saw it.
Run by The Daily Advisor on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 2968385986690789
- Platforms
- Facebook, Instagram and Messenger
- Relaunches
- 10
- EU reach
- 464
Ad text
Explore Retatrutide clinical trials for obesity, including study phases, eligibility criteria, and research goals. Learn more.
Where the ad sends people
TipDrop.com
Explore info about Retatrutide Clinical Trials for Obesity
Learn more: resultsfordeals.com(opens in a new tab)
